2022
DOI: 10.1039/d2nr01500e
|View full text |Cite
|
Sign up to set email alerts
|

Tailoring bismuth-based nanoparticles for enhanced radiosensitivity in cancer therapy

Abstract: Complete response to cancer treatment is an important challenge that has puzzled mankind. Fortunately, radiotherapy gives rise to a common clinical treatment method, during which the usage of radio-sensitizers is...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(9 citation statements)
references
References 86 publications
0
9
0
Order By: Relevance
“…39 As an alternative option, metal-based nanomaterials, especially high-Z materials (eg, Au, bismuth, platinum, gadolinium), have been used in experimental and clinical applications as common radiosensitizers. [40][41][42] Owing to the emission of low-energy photoelectrons and the interaction of Auger electrons, high-Z nanomaterials can absorb, scatter, and eradicate radiation energy. Moreover, when compared with other metal-based nanomaterials, Au-based nanomaterials are most widely used for this purpose, owing to the following advantages it offers: 1) a strong X-ray attenuation 1960 capability that makes it suitable for use in computer tomography (CT) imaging contrast agent and radiosensitizer [43][44][45] ; 2) as it can be easily surface-modified and embedded in structures such as liposomes and polymer particles, it is frequently used in different tumor treatment protocols; 3) as an inert metal, it exhibits good biocompatibility and low biotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…39 As an alternative option, metal-based nanomaterials, especially high-Z materials (eg, Au, bismuth, platinum, gadolinium), have been used in experimental and clinical applications as common radiosensitizers. [40][41][42] Owing to the emission of low-energy photoelectrons and the interaction of Auger electrons, high-Z nanomaterials can absorb, scatter, and eradicate radiation energy. Moreover, when compared with other metal-based nanomaterials, Au-based nanomaterials are most widely used for this purpose, owing to the following advantages it offers: 1) a strong X-ray attenuation 1960 capability that makes it suitable for use in computer tomography (CT) imaging contrast agent and radiosensitizer [43][44][45] ; 2) as it can be easily surface-modified and embedded in structures such as liposomes and polymer particles, it is frequently used in different tumor treatment protocols; 3) as an inert metal, it exhibits good biocompatibility and low biotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…With the help of DP‐BNF@Lat‐MPs as a radiosensitizer and PTT agent, combination therapy could generate excessive levels of ROS which directly damage DNA double strands and induce tumor cell apoptosis. [ 41 ] Moreover, the hypoxic tumor microenvironment limits the therapeutic efficiency of PTT and radiotherapy. The BNFs with the incomplete reduction of Bi 2 O 3 form the nanoflower structure which has the specific Z‐scheme heterostructure and improves the electronic transmission.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, numerous nanoparticles (NPs) have been developed for effective RT, which can inhibit tumor growth by enhancing the deposition of radiation energy in cells, and then target the ROS with their killing effects, leading to excellent radiotherapy sensitivity. 13–16 …”
Section: Introductionmentioning
confidence: 99%
“…Currently, numerous nanoparticles (NPs) have been developed for effective RT, which can inhibit tumor growth by enhancing the deposition of radiation energy in cells, and then target the ROS with their killing effects, leading to excellent radiotherapy sensitivity. [13][14][15][16] In glioma therapy, conventional chemotherapy methods can easily cause hematological toxicity and even induce epilepsy. The structural redesign of traditional chemotherapeutic drugs and improvement of dosage can reduce toxicity and side effects, thereby enhancing the efficacy of the drugs.…”
Section: Introductionmentioning
confidence: 99%